Kidney Cancer Treatment

Treatment options for renal cancer.

When you have kidney cancer, you want the most effective treatment. And you want it right away.

Our kidney surgeons and specialists are pioneers in kidney cancer treatment. We developed techniques for robotic-assisted kidney surgery. That’s why our surgeons can frequently use the robot to save the kidney, often for even the most complex cases.

We know what it takes to treat kidney cancer successfully. We’re here to help you fight -- and win.

Your kidney cancer treatment options

After you receive a kidney cancer diagnosis, we’ll work with you to decide the right course of action.

If your case is particularly challenging, we’ll discuss it at our regular tumor board meeting. This is where we bring together a diverse team of specialists to create treatment plans for difficult cancer cases. The tumor board team includes:

Many different treatment options for kidney cancer are available to you at Henry Ford. Some of these include:

  • Minimally invasive robot-assisted surgery
  • Cryoablation, a nonsurgical treatment we use to freeze and destroy small kidney tumors
  • Traditional open surgery, which is needed in rare cases where tumors are large, complex, or invasive

Another option your kidney doctor may recommend is active observation.

What is active observation?

Active observation -- also known as active surveillance or watchful waiting -- is an alternative to kidney cancer treatment. It involves monitoring your tumors on a regular basis rather than immediately proceeding with a treatment plan.

You might be a candidate for active observation if you:

  • Have kidney tumors that are too small to remove surgically
  • Are an older patient (usually older than 60) whose small kidney tumors have slow growth rates and are unlikely to spread to other areas of the body

Our kidney cancer team will counsel you on options so you and your doctor can decide together when it’s time to act.

Connect with our Cancer Team 24/7

Call us at (888) 777-4167

Clinical Trials

Cancer Institute